Topics

Abzena plc Company Profile

05:38 EDT 20th September 2019 | BioPortfolio

Abzena provides proprietary technologies and complementary services in the UK and USA to enable the development and manufacture of biopharmaceutical products. The development of biopharmaceuticals is a growing area and requires specialist technology.


News Articles [16 Associated News Articles listed on BioPortfolio]

Abzena creates offering for drug candidate optimization

Abzena launches a developability assessment and optimization service to assist customers in selecting and developing lead candidates for manufacture.

Abzena tapped as CMC for Lipum’s biologic development project

Abzena and Lipum enter agreement for the development of biologics for juvenile idiopathic arthritis, using the formerâs proprietary cell line and GMP resources.

Abzena Announces Successful Technical Transfer of Synaffix GlycoConnect™ Antibody Drug Conjugate (ADC) Technology to Enable Use in Client Projects

Abzena, the global partner research organization, announced it has successfully completed a technology transfer and scalability evaluation using the Synaffix technologies of GlycoConnect™ (antibody...

Is Abzena the new force in building better biopharmaceuticals?

Biopharmaceuticals are an increasingly important class of medicines with over 400 products estimated to be in clinical development and the market expected to increase from US$199.7 billion in 2013 to ...

Abzena Announces 14-Month Cell Line to Phase 1 GMP Service and Appointment of Shahram Katousian as Head of Biologics Manufacturing

Abzena, the leading biotherapeutics target to GMP partner research organization (PRO) announced an accelerated program to IND. This reduces timeline from stable pool to GMP down t...

Abzena Expands Leadership Team With Andrew Kraus as Chief Technology Officer and Philip Payne as Chief Commercial Officer

Abzena, the leading global biologics and ADC target partner research organization, announced it has appointed Andrew Kraus as Chief Technology Officer (CTO) and Philip Payne as Chief Commercial Offic...

Abzena’s partner True North Therapeutics subject of US$825m take-over

Abzena, Lipum Sign Integrated CMC Agreement

Will produce a novel biologic for autoimmune inflammatory diseases

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

Abzena

Abzena provides proprietary technologies and complementary services in the UK and US to enable the development and manufacture of biopharmaceuticals.

Abzena plc

Abzena provides proprietary technologies and complementary services in the UK and USA to enable the development and manufacture of biopharmaceutical products. The development of b...

Abzena plc and Telix Pharmaceuticals Limited

“Radio-immunoconjugates have tremendous potential as one of the most adaptable site specific, precision medicines and, in prostate cancer, PSMA is increasingly recognised as ...

More Information about "Abzena plc" on BioPortfolio

We have published hundreds of Abzena plc news stories on BioPortfolio along with dozens of Abzena plc Clinical Trials and PubMed Articles about Abzena plc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Abzena plc Companies in our database. You can also find out about relevant Abzena plc Drugs and Medications on this site too.

Quick Search

Relevant Topics

Complementary and Alternative Medicine
Alternative medicine are whole medical systems that did not fit with conventional medicine as they have completely different philosophies and ideas on the causes of disease, methods of diagnosis and approaches to treatment. Although often overlapping, co...

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open http://www.bioportfolio.com/channels?category_id=5 Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...


Corporate Database Quicklinks



Searches Linking to this Company Record